Bellicum Pharmaceuticals Inc Stock Ownership - Who owns Bellicum Pharmaceuticals?

Insider buying vs selling

Have Bellicum Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLCM insiders and whales buy or sell their stock.

BLCM Shareholders

What type of owners hold Bellicum Pharmaceuticals Inc stock?
Frank B. McGuyer23.33%2,215,398$1.68MInsider
Mcguyer Investments Ltd23.33%2,215,398$1.68MInsider
Remeditex Ventures LLC19.03%1,807,603$1.37MInsider
James F. Brown9.83%933,706$709.62kInsider
Kevin M. Slawin9.40%892,453$678.26kInsider
Ikarian Capital LLC4.72%448,101$340.56kInstitution
Long Focus Capital Management LLC3.45%327,692$249.05kInstitution
Baker Bros Advisors LP3.13%297,675$226.23kInsider
Baker Bros Advisors LP2.62%249,123$189.33kInstitution
Jon P. Stonehouse2.15%204,086$155.11kInsider

1 of 3

BLCM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XCUR0.99%99.01%Net BuyingNet Selling
CNSP2.44%97.56%Net BuyingNet Buying

Bellicum Pharmaceuticals Stock Ownership FAQ

Who owns Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals (NASDAQ: BLCM) is owned by 14.99% institutional shareholders, 98.48% Bellicum Pharmaceuticals insiders, and 0.00% retail investors. Frank B. McGuyer is the largest individual Bellicum Pharmaceuticals shareholder, owning 2.22M shares representing 23.33% of the company. Frank B. McGuyer's Bellicum Pharmaceuticals shares are currently valued at $1.72M.

If you're new to stock investing, here's how to buy Bellicum Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.